{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:19:54Z","timestamp":1783480794976,"version":"3.55.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Tertiary lymphoid structures (TLS) are important ectopic immune aggregates that develop within the tumor microenvironment (TME) of hepatocellular carcinoma (HCC) and have attracted increasing attention due to their potential clinical value. Recent studies have identified TLS as key players in prognosis assessment and immunotherapy response prediction in HCC, with their maturity and spatial distribution being critical determinants of clinical outcomes. TLS can be classified into intratumoral and peritumoral types, which exhibit distinct predictive values; the clinical significance of peritumoral mature TLS remains controversial. Histopathological analysis remains the gold standard for detecting TLS structure and composition. In recent years, predictive models based on CT\/MRI radiomics and machine learning have achieved promising progress in non-invasive detection. This review summarizes and analyzes the formation mechanism of TLS in HCC, emphasizes their structural characteristics, spatial distribution, clinical value, and detection methods, presents current challenges and research directions, and provides a new perspective for the diagnosis and treatment of HCC.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1741542","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T05:26:55Z","timestamp":1777267615000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Research progress of tertiary lymphoid structure in hepatocellular carcinoma: from prognostic biomarkers to new strategies for immunotherapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Shimin","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, Jiujiang University Affiliated Hospital","place":["Jiujiang, China"]},{"name":"Jiangxi Medical College of Nanchang University","place":["Nanchang, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianting","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Jiujiang University Affiliated Hospital","place":["Jiujiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Jiujiang University Affiliated Hospital","place":["Jiujiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Jiujiang University Affiliated Hospital","place":["Jiujiang, China"]},{"name":"Jiangxi Medical College of Nanchang University","place":["Nanchang, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Jiujiang University Affiliated Hospital","place":["Jiujiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Jiujiang University Affiliated Hospital","place":["Jiujiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Jiujiang University Affiliated Hospital","place":["Jiujiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zipeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Jiujiang University Affiliated Hospital","place":["Jiujiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongnuo","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Jiujiang University Affiliated Hospital","place":["Jiujiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongcai","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Jiujiang University Affiliated Hospital","place":["Jiujiang, China"]},{"name":"Jiangxi Medical College of Nanchang University","place":["Nanchang, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfu","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Jiujiang University Affiliated Hospital","place":["Jiujiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2021.01094","article-title":"Surgical treatment of hepatocellular carcinoma","volume":"15","author":"Sugawara","year":"2021","journal-title":"Biosci Trends"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1210802","article-title":"Bibliometric study of immunotherapy for hepatocellular carcinoma","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.21037\/hbsn-22-579","article-title":"Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives","volume":"13","author":"Herrero","year":"2024","journal-title":"Hepatobil Surg Nutr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.09.035","article-title":"Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score","volume":"76","author":"Scheiner","year":"2022","journal-title":"J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7150\/thno.102995","article-title":"DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma","volume":"14","author":"Wang","year":"2024","journal-title":"Theranostics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-1213","article-title":"Combination therapies for advanced hepatocellular carcinoma: Biomarkers and unmet needs","volume":"28","author":"Cappuyns","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1370771","article-title":"Predicting effect of anti-PD-1\/PD-L1 inhibitors therapy for hepatocellular carcinoma by detecting plasma metabolite based on UHPLC-MS","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn-22-527","article-title":"Pathologic assessment of hepatocellular carcinoma in the era of immunotherapy: A narrative review","volume":"13","author":"Wang","year":"2024","journal-title":"Hepatobil Surg Nutr"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1369626","article-title":"Tertiary lymphoid structures in cancer: maturation and induction","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00706-z","article-title":"The roles of tertiary lymphoid structures in chronic diseases","volume":"19","author":"Sato","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0697","article-title":"Role of B cells in responses to checkpoint blockade immunotherapy and overall survival of cancer patients","volume":"27","author":"Kim","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1473969","article-title":"Tertiary lymphoid structures: Exploring opportunities to improve immunotherapy in ovarian cancer","volume":"16","author":"Varghese","year":"2025","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"100546","DOI":"10.1016\/j.medj.2024.10.023","article-title":"Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside","volume":"6","author":"Peyraud","year":"2025","journal-title":"Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-011617","article-title":"Review: Radiotherapy-mediated B cells within the TLS influence the tumor microenvironment","volume":"13","author":"Yang","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01992-w","article-title":"Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma","volume":"25","author":"Shu","year":"2024","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s43018-021-00234-4","article-title":"Neoadjuvant cabozantinib and nivolumab converts locally advanced HCC into resectable disease with enhanced antitumor immunity","volume":"2","author":"Ho","year":"2021","journal-title":"Nat Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-011126","article-title":"Transfer learning radiomic model predicts intratumoral tertiary lymphoid structures in hepatocellular carcinoma: a multicenter study","volume":"13","author":"Long","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-025-11902-9","article-title":"Noninvasive MRI imaging feature-based prediction of intratumoral tertiary lymphoid structure maturity in hepatocellular carcinoma: A multicenter retrospective study","volume":"36","author":"Li","year":"2025","journal-title":"Eur Radio"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-1594","article-title":"Chemotherapy drives tertiary lymphoid structures that correlate with ICI-responsive TCF1+CD8+ T cells in metastatic ovarian cancer","volume":"31","author":"Lanickova","year":"2025","journal-title":"Clin Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.157215","article-title":"CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer","volume":"7","author":"Ukita","year":"2022","journal-title":"JCI Insight"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/imr.70047","article-title":"Perivascular tertiary lymphoid structures in autoimmune disease","volume":"332","author":"Goronzy","year":"2025","journal-title":"Immunol Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1158\/0008-5472.CAN-23-2716","article-title":"LT\u03b2R agonism promotes antitumor immune responses via modulation of the tumor microenvironment","volume":"84","author":"An","year":"2024","journal-title":"Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217491","article-title":"Tertiary lymphoid structures as a biomarker in immunotherapy and beyond: Advancing towards clinical application","volume":"613","author":"Cui","year":"2025","journal-title":"Cancer Lett"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105003","article-title":"Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer","volume":"101","author":"Di Modugno","year":"2024","journal-title":"EBioMedicine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","article-title":"CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis","volume":"42","author":"Zhang","year":"2024","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1348156","article-title":"Epigenetic targets to enhance antitumor immune response through the induction of tertiary lymphoid structures","volume":"15","author":"Omotesho","year":"2024","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101448","article-title":"An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the tfh-dependent tertiary lymphoid structure","volume":"5","author":"Liu","year":"2024","journal-title":"Cell Rep Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1147480","article-title":"Deciphering the maturation of tertiary lymphoid structures in cancer and inflammatory diseases of the digestive tract using imaging mass cytometry","volume":"14","author":"Le Rochais","year":"2023","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1413067","article-title":"Mature tertiary lymphoid structures: Important contributors to anti-tumor immune efficacy","volume":"15","author":"Bao","year":"2024","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1016\/j.immuni.2024.11.010","article-title":"Skin immune-mesenchymal interplay within tertiary lymphoid structures promotes autoimmune pathogenesis in hidradenitis suppurativa","volume":"57","author":"Yu","year":"2024","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.36401\/JIPO-22-10","article-title":"The role of interleukin-7 in the formation of tertiary lymphoid structures and their prognostic value in gastrointestinal cancers","volume":"5","author":"Ware","year":"2022","journal-title":"J Immunother Precis Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216293","article-title":"Tertiary lymphoid structures and cytokines interconnections: The implication in cancer immunotherapy","volume":"568","author":"Li","year":"2023","journal-title":"Cancer Lett"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-021-09792-8","article-title":"High endothelial venules (HEVs) in immunity, inflammation and cancer","volume":"24","author":"Blanchard","year":"2021","journal-title":"Angiogenesis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.ccell.2025.03.011","article-title":"Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures","volume":"43","author":"Tang","year":"2025","journal-title":"Cancer Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41392-025-02308-6","article-title":"Differential expression pattern of CC chemokine receptor 7 guides precision treatment of hepatocellular carcinoma","volume":"10","author":"Qin","year":"2025","journal-title":"Signal Transd Targ Ther"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1038\/s41467-022-32283-3","article-title":"A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma","volume":"13","author":"Lu","year":"2022","journal-title":"Nat Commun"},{"key":"B42","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","article-title":"Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transd Targ Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13046-025-03490-9","article-title":"Targeting tumor-associated macrophages to overcome immune checkpoint inhibitor resistance in hepatocellular carcinoma","volume":"44","author":"Liu","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"102298","DOI":"10.1016\/j.xcrm.2025.102298","article-title":"Enhanced formation of tertiary lymphoid structures shapes the anti-tumor microenvironment in hepatocellular carcinoma after FOLFOX-HAIC therapy","volume":"6","author":"Xing","year":"2025","journal-title":"Cell Rep Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1652433","article-title":"Intratumoral bacterial load and tertiary lymphoid structure density in hepatocellular carcinoma: association and prognostic significance","volume":"16","author":"Qu","year":"2025","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000825","article-title":"Glutathione synthesis via the cystine\/glutamate transporter promotes the formation of tertiary lymphoid structures in the kidney","volume":"37","author":"Arai","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1007426","article-title":"Protective effect of tertiary lymphoid structures against hepatocellular carcinoma: New findings from a genetic perspective","volume":"13","author":"Jia","year":"2022","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15865","article-title":"Characterization of lymphocyte-rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures","volume":"44","author":"Ahn","year":"2024","journal-title":"Liv Int"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309348","article-title":"The absence of intra-tumoral tertiary lymphoid structures is associated with a worse prognosis and mTOR signaling activation in hepatocellular carcinoma with liver transplantation: A multicenter retrospective study","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-2589","article-title":"Spatial positioning of immune hotspots reflects the interplay between B and T cells in lung squamous cell carcinoma","volume":"83","author":"Zhang","year":"2023","journal-title":"Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009879","article-title":"Spatial patterns and MRI-based radiomic prediction of high peritumoral tertiary lymphoid structure density in hepatocellular carcinoma: a multicenter study","volume":"12","author":"Long","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.648812","article-title":"Peritumoral tertiary lymphoid structures correlate with protective immunity and improved prognosis in patients with hepatocellular carcinoma","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2024.102144","article-title":"Lymphocyte function in tertiary lymphoid structures predicts hepatocellular carcinoma outcome","volume":"104","author":"Li","year":"2024","journal-title":"Lab Invest"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1422206","article-title":"Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring","volume":"15","author":"Berthe","year":"2024","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1390938","article-title":"Prognostic value of tertiary lymphoid structures in hepatocellular carcinoma: a meta-analysis and systematic review","volume":"15","author":"Hu","year":"2024","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005531","article-title":"Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer","volume":"10","author":"Sun","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.870458","article-title":"Tertiary lymphatic structures in primary hepatic carcinoma: controversy cannot overshadow hope","volume":"13","author":"Jia","year":"2022","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200269RR","article-title":"Tertiary lymphoid structures: associated multiple immune cells and analysis their formation in hepatocellular carcinoma","volume":"36","author":"Nie","year":"2022","journal-title":"FASEB J"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1289753","article-title":"The enrichment of the gut microbiota Lachnoclostridium is associated with the presence of intratumoral tertiary lymphoid structures in hepatocellular carcinoma","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-024-11255-9","article-title":"A novel hybrid model for predicting tertiary lymphoid structures and targeted immunotherapy outcomes in hepatocellular carcinoma: a multicenter retrospective study","volume":"35","author":"Li","year":"2025","journal-title":"Eur Radiol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2022.110309","article-title":"Preoperative prediction of intra-tumoral tertiary lymphoid structures based on CT in hepatocellular cancer","volume":"151","author":"Li","year":"2022","journal-title":"Eur J Radiol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S508357","article-title":"Application of intravoxel incoherent motion in the prediction of intra-tumoral tertiary lymphoid structures in hepatocellular carcinoma","volume":"12","author":"Ma","year":"2025","journal-title":"J Hepatocell Carcin"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216513","article-title":"Spatial multimodal analysis revealed tertiary lymphoid structures as a risk stratification indicator in combined hepatocellular-cholangiocarcinoma","volume":"581","author":"Gan","year":"2024","journal-title":"Cancer Lett"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000003045","article-title":"Refining risk stratification in hepatocellular carcinoma by integrating tertiary lymphoid structures and microvascular invasion: a multicenter retrospective study","volume":"111","author":"Ma","year":"2025","journal-title":"Int J Surg"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1741542\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:10:03Z","timestamp":1778141403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1741542\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":64,"alternative-id":["10.3389\/fimmu.2026.1741542"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1741542","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"article-number":"1741542"}}